CoChat

A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS

Open access
Niespodziana, Katarzyna, Focke-Tejkl, Margarete, Linhart, Birgit, Civaj, Vera, Blatt, Katharina, Valent, Peter, van Hage, Marianne, Grönlund, Hans, Valenta, Rudolf · 2011 · Journal of Allergy and Clinical Immunology
Cited by 105

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background Allergen-specific immunotherapy is clinically effective for the treatment of cat allergy but shows a high rate of side effects. Objective We sought to engineer recombinant fusion proteins for cat immunotherapy that allow reducing both IgE-mediated and T cell–mediated side effects. Methods Fusion proteins consisting of the hepatitis B virus–derived PreS domain and 2 nonallergenic Fel d 1–derived peptides were expressed in Escherichia coli and purified. IgE reactivity and allergenic activity of Fel d 1 and the fusion proteins were compared by using IgE-binding assays and basophil activation tests in patients with cat allergy. Mice and rabbits were immunized subcutaneously with Fel d 1 and the fusion proteins to investigate the allergenicity of the vaccines and the development of Fel d 1–specific IgG antibodies. Results The recombinant fusion proteins showed no relevant IgE reactivity and exhibited more than 1000-fold reduced allergenic activity in basophil activation tests. On immunization of mice and rabbits, the fusion proteins induced Fel d 1–specific IgG antibodies that inhibited the binding of allergic patients’ IgE to the allergen without allergic sensitization to Fel d 1. Conclusion The described recombinant fusion proteins exhibit strongly reduced IgE-mediated allergenic activity, contain less than 40% of the Fel d 1 sequence, and thus lack many of the specific T-cell epitopes. Therefore they should represent safe vaccines for the treatment of cat allergy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2011.02.004

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 105

Metadata

Authors
Niespodziana, K., Focke-Tejkl, M., Linhart, B., Civaj, V., Blatt, K., Valent, P., van Hage, M., Grönlund, H., & Valenta, R.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2011-06
Volume
127
Issue
6
Pages
1562-1570.e6
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2078129223
Cited by
105
References
5
FWCI
7.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS. https://app.cochat.ai/papers/10.1016/j.jaci.2011.02.004
The paper
Niespodziana, K., Focke-Tejkl, M., Linhart, B., Civaj, V., Blatt, K., Valent, P., van Hage, M., Grönlund, H., & Valenta, R. (2011). A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2011.02.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.